1832 Asset Management L.P. Cuts Stock Position in CME Group Inc. (NASDAQ:CME)

1832 Asset Management L.P. cut its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 6.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 846,307 shares of the financial services provider’s stock after selling 62,608 shares during the quarter. 1832 Asset Management L.P. owned 0.24% of CME Group worth $166,384,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in CME. Gold Investment Management Ltd. purchased a new stake in shares of CME Group during the fourth quarter worth $26,000. Salomon & Ludwin LLC purchased a new stake in CME Group during the 1st quarter valued at about $28,000. Y.D. More Investments Ltd purchased a new stake in CME Group during the 2nd quarter valued at about $36,000. McClarren Financial Advisors Inc. grew its stake in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares in the last quarter. Finally, Asset Dedication LLC grew its stake in CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

Shares of CME stock opened at $213.16 on Friday. The firm’s 50 day moving average price is $207.86 and its 200-day moving average price is $207.45. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $223.80. The firm has a market cap of $76.75 billion, a P/E ratio of 24.25, a P/E/G ratio of 8.85 and a beta of 0.55.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the business posted $2.30 EPS. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. As a group, equities research analysts predict that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be issued a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.16%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Analyst Ratings Changes

Several analysts recently issued reports on CME shares. Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $212.00 to $177.00 in a research note on Tuesday, September 3rd. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Barclays boosted their target price on shares of CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Four equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $209.73.

Check Out Our Latest Analysis on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.